What is hmpv virus

What is HMPV?

Human metapneumovirus (HMPV) is a respiratory virus that belongs to the family of negative-sense, single-stranded RNA viruses. It was first discovered and identified in 2001 in respiratory samples from Dutch children. Since its discovery, HMPV has been recognized worldwide as an important cause of respiratory tract infections across all age groups.

How HMPV Spreads

HMPV spreads through respiratory droplets when an infected person coughs or sneezes. The virus can also spread through direct contact with respiratory secretions or contaminated surfaces. People are typically contagious for 3-7 days after symptoms begin. Close contact with infected individuals, such as in schools, childcare facilities, and healthcare settings, increases the risk of transmission.

Symptoms and Clinical Presentation

Symptoms of HMPV infection typically appear 4-6 days after exposure. Common symptoms include:

• Cough (often dry initially, then productive)
• Fever
• Nasal congestion and runny nose
• Sore throat
• Shortness of breath or wheezing
• Muscle aches and fatigue

In severe cases, particularly in young children, elderly people, or immunocompromised individuals, HMPV can cause bronchiolitis (inflammation of small airways) or pneumonia.

Seasonality and Epidemiology

HMPV infections are most common during winter months in temperate climates, though they can occur year-round in tropical regions. Most children have been infected with HMPV by age five. The virus typically circulates in two-year cycles with varying intensity across different regions.

Diagnosis and Treatment

HMPV diagnosis is confirmed through molecular tests such as RT-PCR on respiratory samples. Currently, there is no specific antiviral treatment for HMPV. Management focuses on supportive care including rest, hydration, and fever management. Severe cases may require hospitalization for oxygen therapy and respiratory support.